企業プロフィール
Cel-Sci Corporation 株価・ニュース・カタリスト
- ティッカー:
- CVM
- 取引所:
- AMEX
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
1.55 USD (+0.65%)
終値
最終更新: 2026年8月17日
21.6M USD
時価総額
株価変動の要因
As of Aug 17, 2026, CVM closed up 0.65% at $1.55. No new same-company headline was identified in the current news window.
企業概要
事業概要
Cel-Sci is a biotechnology company focused on immunotherapy and cancer vaccine approaches. Its story has long centered on a high-risk, high-conviction immune-oncology platform.
所在地とセクター分類
Headquartered in the United States and listed on NYSE American, Cel-Sci sits in oncology biotechnology.
ビジネスモデルの特徴
The company depends on clinical validation, regulatory progress, and the ability to create a differentiated immunotherapy story.
バイオ業界での位置付け
Cel-Sci is a classic high-beta oncology name whose stock is extremely sensitive to trial outcomes.
今後のカタリスト
- Cel-Sci’s catalysts are Multikine-related regulatory or development steps, with any update on the head-and-neck cancer story being the key event. The company’s stock remains highly event-driven.
最近のニュース
- 01
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。